Geode Capital Management
OKUR

Geode Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Geode Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Buy
98,750
+21,281
+27% +$65.7K ﹤0.01% 3656
2025
Q4 		$225K Sell
77,469
-7,426
-9% -$22.2K ﹤0.01% 3862
2025
Q3 		$233K Hold
84,895
– – ﹤0.01% 3872
2025
Q2 		$203K Sell
84,895
-1,416
-2% -$3.71K ﹤0.01% 3865
2025
Q1 		$371K Buy
86,311
+9,712
+13% +$54.6K ﹤0.01% 3652
2024
Q4 		$659K Buy
76,599
+55,149
+257% +$835K ﹤0.01% 3517
2024
Q3 		$365K Buy
21,450
+1,346
+7% +$19.9K ﹤0.01% 3702
2024
Q2 		$304K Sell
20,104
-13,166
-40% -$223K ﹤0.01% 3761
2024
Q1 		$552K Sell
33,270
-684
-2% -$11.3K ﹤0.01% 3574
2023
Q4 		$543K Buy
33,954
+891
+3% +$55.5K ﹤0.01% 3581
2023
Q3 		$2.52M Buy
33,063
+3,617
+12% +$246K ﹤0.01% 2989
2023
Q2 		$1.93M Buy
29,446
+19,785
+205% +$1.59M ﹤0.01% 3125
2023
Q1 		$578K Buy
9,661
+830
+9% +$30.1K ﹤0.01% 3586
2022
Q4 		$205K Sell
8,831
-19
-0.2% -$504 ﹤0.01% 4082
2022
Q3 		$296K Buy
8,850
+3,514
+66% +$115K ﹤0.01% 3997
2022
Q2 		$141K Sell
5,336
-6,780
-56% -$158K ﹤0.01% 4438
2022
Q1 		$356K Buy
12,116
+192
+2% +$10.7K ﹤0.01% 4115
2021
Q4 		$1.02M Sell
11,924
-143
-1% -$10.5K ﹤0.01% 3714
2021
Q3 		$898K Buy
12,067
+4,860
+67% +$412K ﹤0.01% 3737
2021
Q2 		$672K Buy
+7,207
New +$804K ﹤0.01% 3796

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management's OKUR Position: Q1 2026 in Review

Geode Capital Management increased its OnKure Therapeutics (OKUR) stake by 27% in Q1 2026, buying an estimated $65.7K and bringing the position to 98,750 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #3656.

Geode Capital Management first reported a position in OKUR in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.52M in Q3 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Geode Capital Management held 98,750 shares of OnKure Therapeutics worth $409K as of Q1 2026.
  • Geode Capital Management bought 21,281 OnKure Therapeutics shares in Q1 2026, an estimated $65.7K.
  • OnKure Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3656 holding.
  • Geode Capital Management first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's OnKure Therapeutics position peaked at $2.52M in Q3 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.